Try a new search

Format these results:

Searched for:



Total Results:


Commentary: Spooky action at a distance-an example of ventricular entanglement [Editorial]

Balsam, Leora B; Grossi, Eugene A
PMID: 32977968
ISSN: 1097-685x
CID: 4616232

Commentary: "Kicking the can down the road"

James, Les; Grossi, Eugene A
PMID: 35398925
ISSN: 1540-8191
CID: 5218872

Commentary: Going with the flow-But do we have to be careful of the rapids downstream? [Editorial]

Nafda, Heidi B; Grossi, Eugene A
PMID: 32536407
ISSN: 1097-685x
CID: 4484442

One-Year Outcomes With Venovenous Extracorporeal Membrane Oxygenation Support for Severe COVID-19

Smith, Deane E; Chang, Stephanie H; Geraci, Travis C; James, Les; Kon, Zachary N; Carillo, Julius A; Alimi, Marjan; Williams, David; Scheinerman, Joshua A; Cerfolio, Robert J; Grossi, Eugene A; Moazami, Nader; Galloway, Aubrey C
BACKGROUND:Severe coronavirus disease 2019 (COVID-19) can cause acute respiratory failure requiring mechanical ventilation. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) has been used in patients in whom conventional mechanical ventilatory support has failed. To date, published data have focused on survival from ECMO and survival to discharge. In addition to survival to discharge, this study reports 1-year follow-up data for patients who were successfully discharged from the hospital. METHODS:A single-institution, retrospective review of all patients with severe COVID-19 who were cannulated for VV-ECMO between March 10, 2020 and May 1, 2020 was performed. A multidisciplinary ECMO team evaluated, selected, and managed patients with ECMO support. The primary outcome of this study was survival to discharge. Available 1-year follow-up data are also reported. RESULTS:A total of 30 patients were supported with VV-ECMO, and 27 patients (90%) survived to discharge. All patients were discharged home or to acute rehabilitation on room air, except for 1 patient (3.7%), who required supplemental oxygen therapy. At a median follow-up of 10.8 months (interquartile range [IQR], 8.9-14.4 months) since ECMO cannulation, survival was 86.7%, including 1 patient who underwent lung transplantation. Of the patients discharged from the hospital, 44.4% (12/27) had pulmonary function testing, with a median percent predicted forced expiratory volume of 100% (IQR, 91%-110%). For survivors, a 6-minute walk test was performed in 59.3% (16/27), with a median value of 350 m (IQR, 286-379 m). CONCLUSIONS:A well-defined patient selection and management strategy of VV-ECMO support in patients with severe COVID-19 resulted in exceptional survival to discharge that was sustained at 1-year after ECMO cannulation.
PMID: 35282865
ISSN: 1552-6259
CID: 5183722

Commentary: You have to work hard…to make it simple [Editorial]

Nafday, Heidi B; Grossi, Eugene A
PMID: 32727680
ISSN: 1097-685x
CID: 4540342

Reply: Crossing the Rubicon-Ventricular dimension controls the ultimate fate of ischemic mitral regurgitation procedures [Letter]

Nafday, Heidi B; Grossi, Eugene A
PMID: 33744013
ISSN: 1097-685x
CID: 4822072

Commentary: Just shy of a bullseye! [Editorial]

James, Les; Grossi, Eugene A
PMID: 34953567
ISSN: 1097-685x
CID: 5107912

Semirigid posterior annuloplasty band: Reshaping the mitral orifice while preserving its physiology [Editorial]

James, Les; Grossi, Eugene A; Loulmet, Didier F; Galloway, Aubrey C
PMID: 34977703
ISSN: 2666-2507
CID: 5106842

Commentary: London Bridge is falling down-how will we build it up? [Editorial]

James, Les; Grossi, Eugene A
PMID: 34977711
ISSN: 2666-2507
CID: 5106852

Commentary: A shoestring catch… [Comment]

D'Angelo, Michael; James, Les; Grossi, Eugene A
PMID: 34984384
ISSN: 2666-2507
CID: 5107082